Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia

ISSN： 1173-8804

Source： BioDrugs, Vol.19, Iss.1, 2005-01, pp. : 9-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV‐infected patient on antiretroviral therapy: a case report and review of the literature

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 453-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Current Drug Therapy, Vol. 7, Iss. 4, 2012-12 ,pp. : 281-289

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

By Cvetković Risto S. Perry Caroline M.

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 253-257

Adis International

Access to resources Recommend Favorite

Spotlight on Rituximab in Chronic Lymphocytic Leukemia, Low-Grade or Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma†

By Keating Gillian M.

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 55-61

Adis International

Access to resources Recommend Favorite

Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

By Breccia Massimo Alimena Giuliana

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite